Skin Imaging to Assess the Effects of Tretinoin Cream and Skin Smoothing Laser Using Optic Imaging Technologies



Status:Recruiting
Healthy:No
Age Range:45 - Any
Updated:4/21/2016
Start Date:August 2015
End Date:March 2018
Contact:Mihaela Balu, PhD
Email:mbalu@uci.edu
Phone:949.824.7997

Use our guide to learn which trials are right for you!

In-vivo Non-invasive Skin Imaging Pilot Study to Assess the Effects of Tretinoin Cream and Skin Smoothing Laser™ Using Multi-photon Microscopy and Multi-spectral Imaging

The researchers want to assess the effectiveness of Tretinoin cream and of the Food and Drug
Administration cleared Skin Smoothing Laser to determine the change of the skin using
optical imaging techniques to measure the change.

The researchers can determine the change of skin properties during application of Tretinoin
cream and Skin Smoothing Laser by the optical imaging techniques.

The imaging technologies used in this study are:

1. Multiphoton microscopy to evaluate the changes in the skin following application of
cosmetic products

2. Multispectral Imaging this imaging modality for obtaining information on the skin's
optical properties

Topical cream used in this study is Tretinoin cream 0.1% is to determine the improvement of
collagen/elastin damages in forearm skin.

Skin Smoothing Laser is cosmetic light treatment use in this study is to stimulating new
production of new skin cell.

Inclusion Criteria:

- Female 45 years of age or older - Skin type scale I to III

Exclusion Criteria:

- Large amount of dark, coarse hair on the arms

- History of allergies to alpha hydroxy acids (AHAs), retinoids, soaps, fragrances,
sunscreens or Latex

- Currently using over-the-counter AHA or retinol within one month or prescription
retinoid within three months of the start of the study.

- History of skin cancer, including squamous or basal cell carcinoma at the treatment
site or history of malignant melanoma.

- History of diabetes

- Currently pregnant or nursing
We found this trial at
1
site
Irvine, California 92612
Principal Investigator: Mihaela Balu, PhD
Phone: 949-824-8797
?
mi
from
Irvine, CA
Click here to add this to my saved trials